Related Experiment Videos
Summary
Myoglobinemia is common in active myositis patients. Steroid therapy significantly reduces myoglobin levels, often before enzyme markers normalize, indicating its utility in tracking disease activity.
Area of Science:
- Rheumatology
- Clinical Chemistry
- Biomarkers
Background:
- Myoglobin is a muscle protein.
- Elevated myoglobin in serum (myoglobinemia) can indicate muscle damage.
Purpose of the Study:
- To investigate the presence and clinical significance of myoglobinemia in patients with inflammatory myopathies.
Main Methods:
- Serum myoglobin levels were measured in patients with dermatomyositis, polymyositis, scleroderma, and systemic lupus erythematosus with active myopathy.
- Comparison of myoglobin levels before and after steroid therapy.
- Correlation of myoglobinemia with serum enzyme activities (creatine phosphokinase, lactic dehydrogenase, SGOT) and clinical symptoms.
Main Results:
- Myoglobinemia was detected in 74.1% of patients with active myositis before therapy.
- Steroid therapy reduced myoglobinemia frequency to 43.4% and 9.5% in patients in remission.
- Serum enzyme activity was higher in myoglobin-positive samples, but with overlap.
- Serum myoglobin levels decreased rapidly with therapy, often preceding normalization of enzyme values.
Conclusions:
- Myoglobinemia is a frequent finding in active myositis.
- Serum myoglobin is a sensitive indicator of muscle damage and therapeutic response in myositis.
- Myoglobinemia may be a more sensitive marker of disease activity and exacerbations than traditional enzyme tests.